Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Amiodarone
63%
Heart Arrhythmia
58%
Antiarrhythmic Agent
50%
Antiarrhythmic Drug
50%
Drug-Drug Interaction
41%
Direct Oral Anticoagulant
36%
Etacizine
33%
Anticoagulant Agent
33%
Recurrent Disease
33%
Beta Adrenergic Receptor Blocking Agent
33%
Warfarin
29%
Rivaroxaban
26%
Dabigatran
26%
Persistent Atrial Fibrillation
25%
Aldosterone
25%
Angiotensin
25%
Renin
25%
Recurrence Risk
19%
Proton Pump Inhibitor
19%
Omega-3 Fatty Acid
17%
Propafenone
16%
Congestive Heart Failure
16%
Thromboembolism
15%
Mineralocorticoid Antagonist
13%
Comorbidity
11%
Drug Interaction
10%
Anticoagulation Therapy
10%
Coronary Artery Disease
8%
Drug Concentration
8%
Pharmacodynamics
8%
Diabetes Mellitus
8%
Cardiovascular Risk
8%
Dyslipidemia
8%
Heart Death
8%
Heart Infarction
8%
Pharmacokinetics
8%
Antiinflammatory Agent
8%
Antithrombotic Therapy
8%
Monotherapy
8%
Acetylsalicylic Acid
8%
Prospective Study
8%
Drug Choice
8%
Antivitamin K
7%
Dipeptidyl Carboxypeptidase Inhibitor
5%
Angiotensin Receptor Antagonist
5%
Nursing and Health Professions
Recurrence Risk
25%
Atrial Fibrillation
25%
Anamnesis
25%
Anticoagulant Agent
16%
Warfarin
16%
University Hospital
16%
Proton Pump Inhibitor
10%
Anticoagulation
8%
Congestive Heart Failure
8%
Medical Record
8%
Prevalence
8%
Coronary Artery Disease
8%
Cerebrovascular Accident
8%
CHA2DS2-VASc Score
8%
Percutaneous Coronary Intervention
8%
Heart Left Ventricle Ejection Fraction
8%
Transient Ischemic Attack
7%
Medicine and Dentistry
Atrial Fibrillation
25%
Cardioversion
25%
Recurrence Risk
25%
Cardiovascular System
25%
Etacizine
12%
Sinus Rhythm
7%
Apoplexy
7%
Transient Ischemic Attack
7%
Recurrent Disease
5%
Drug Choice
5%
Myocardial Infarction
5%